透過您的圖書館登入
IP:18.218.254.122
  • 期刊

低危險妊娠性滋養層疾病之治療

The Best Treatment of Low-Risk Nonmetastatic Trophoblastic Disease

摘要


低危險妊娠性滋養層疾病(GTD)係指患者缺乏臨床上高危險因子,或WHO計分分數≦6。通常低危險性GTD只須用一種藥物來治療,但至今仍沒有報告比較過,哪一種藥物爲最理想。經文獻回顧,較理想藥方有3種,即口服methotrexate (MTX),點滴注射MTX 100mg/平方公尺和脈搏性actinomycin,但以脈搏性actinomycin可能爲最理想。

並列摘要


Patients with nonmetastatic gestational trophoblastic disease who lack any of the clinical high-risk factors or have a WHO risk score loss than 6 have low-risk disease, they can be treated successfully with initial single-agent regimens. However, the best protocol for treating low-risk trophoblastic disease is uncertain. Ramdomized comparisons of these regimens have not been completed. The following regimens were judged to be superior based after the literature review: oral methotrexate, infusional methotreate 100 mg/m^2 and pulse actinomycin, but pulse actinomycin appeared to be the preferred choice.

延伸閱讀